Aktienanalyse zu American Well Corporation (AMWL)AMWLAmerican Well Corporation

American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations. It operates in the Healthcare sector (SERVICES-BUSINESS SERVICES, NEC industry).

American Well Corp (AMWL) is a good buy right now, trading at $11.93 with a strong year-to-date change of +145.98%. The company has shown resilience with a narrowed net loss of $9.6 million in Q2 2026, and revenue guidance for Q3 is set between $46 million and $48 million, indicating potential for growth. However, the main risk is the forward P/E of 0, suggesting uncertainty in profitability expectations.